Cercar

16/08/2023 Lights and shadows of the 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.
Martín-Rioboó E, Brotons-Cuixart C, Ruiz García A, Villafañe Sanz F, Frías Vargas M, Moyá Amengual A, Divisón Garrote JA, Seoane Vicente MC, Banegas JR, Pallarés Carratalá V. Lights and shadows of the 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.. Revista Espanola de Salud Publica. 2023; 97DOI:. PMID:37921403. IF:(Q/D).
01/08/2023 An international multidisciplinary consensus statement on MAFLD and the risk of CVD
Zhou, XD, Targher, G, Byrne, CD, Somers, V, Kim, SU, Chahal, CAA, Wong, VWS, Cai, JJ, Shapiro, MD, Eslam, M, Steg, PG, Sung, KC, Misra, A, Li, JJ, Brotons, C, Huang, YL, Papatheodoridis, GV, Sun, AJ, Yilmaz, Y, Chan, WK, Huang, H, Mendez-Sanchez, N, Alqahtani, SA, Cortez-Pinto, H, Lip, GYH, de Knegt, RJ, Ocama, P, Romero-Gomez, M, Fudim, M, Sebastiani, G, Son, JW, Ryan, JD, Ikonomidis, I, Treeprasertsuk, S, Pastori, D, Lupsor-Platon, M, Tilg, H, Ghazinyan, H, Boursier, J, Hamaguchi, M, Nguyen, MH, Fan, JG, Goh, GBB, Al Mahtab, M, Hamid, S, Perera, N, George, J, Zheng, MH. An international multidisciplinary consensus statement on MAFLD and the risk of CVD. Hepatology International. 2023; 17(4)DOI:10.1007/s12072-023-10543-8. PMID:37204656. IF:5.900(Q1/2D).
19/07/2023 Impact of Molnupiravir Treatment on Patient-Reported Coronavirus Disease 2019 (COVID-19) Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled Trial
Guan, YF, Puenpatom, A, Johnson, MG, Zhang, Y, Zhao, YJ, Surber, J, Weinberg, A, Brotons, C, Kozlov, R, Lopez, R, Coetzee, K, Santiaguel, J, Du, JJ, Williams-Diaz, A, Brown, M, Paschke, A, De Anda, C, Norquist, JM. Impact of Molnupiravir Treatment on Patient-Reported Coronavirus Disease 2019 (COVID-19) Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled Trial. CLINICAL INFECTIOUS DISEASES. 2023; 77(11)DOI:10.1093/cid/ciad409. PMID:37466374. IF:8.200(Q1/1D).
01/06/2023 Association between periodontal diseases and cardiovascular diseases, diabetes and respiratory diseases: Consensus report of the Joint Workshop by the European Federation of Periodontology (EFP) and the European arm of the World Organization of Family Doctors (WONCA Europe)
Herrera, D, Sanz, M, Shapira, L, Brotons, C, Chapple, I, Frese, T, Graziani, F, Hobbs, FDR, Huck, O, Hummers, E, Jepsen, S, Kravtchenko, O, Madianos, P, Molina, A, Ungan, M, Vilaseca, J, Windak, A, Vinker, S. Association between periodontal diseases and cardiovascular diseases, diabetes and respiratory diseases: Consensus report of the Joint Workshop by the European Federation of Periodontology (EFP) and the European arm of the World Organization of Family Doctors (WONCA Europe). JOURNAL OF CLINICAL PERIODONTOLOGY. 2023; 50(6)DOI:10.1111/jcpe.13807. PMID:36935200. IF:5.800(Q1/1D).
01/05/2023 Normal Infrarenal Aortic Diameter in Men and Women in a Mediterranean Area
Gené Mola A., Casasa A., Puig Reixach T., de La Figuera M., Jimenez M.J., Fité Matamoros J., Roman Escudero J., Bellmunt Montoya S.. Normal Infrarenal Aortic Diameter in Men and Women in a Mediterranean Area. ANNALS OF VASCULAR SURGERY. 2023; 92DOI:10.1016/j.avsg.2022.12.087. PMID:36639098. IF:1.400(Q3/6D).
01/11/2022 Effectiveness and Cost-Effectiveness of Case Management in Advanced Heart Failure Patients Attended in Primary Care: A Systematic Review and Meta-Analysis
Checa, C, Canelo-Aybar, C, Suclupe, S, Ginesta-Lopez, D, Berenguera, A, Castells, X, Brotons, C, Posso, M. Effectiveness and Cost-Effectiveness of Case Management in Advanced Heart Failure Patients Attended in Primary Care: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health. 2022; 19(21)DOI:10.3390/ijerph192113823. PMID:36360704. IF:4.614(Q1/3D).
01/09/2022 Statement of the Spanish interdisciplinary vascular prevention committee on the updated European guidelines on cardiovascular disease prevention 2021
Brotons, C, Camafort, M, Castellanos, MD, Clara, A, Cortes, O, Rodriguez, AD, Elosua, R, Gorostidi, M, Hernandez, AM, Herranz, M, Justo, S, Lahoz, C, Nino, P, Pallares-Carratala, V, Pedro-Botet, J, Perez, AP, Royo-Bordonada, MA, Santamaria, R, Tresserras, R, Zamora, A, Zuza, I, Armario, P. Statement of the Spanish interdisciplinary vascular prevention committee on the updated European guidelines on cardiovascular disease prevention 2021. Angiologia. 2022; 74(5)DOI:10.20960/angiologia.00411. PMID:. IF:(Q/D).
01/07/2022 Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention
Brotons, C, Camafort, M, Castellanos, MD, Clara, A, Cortes, O, Rodriguez, AD, Elosua, R, Gorostidi, M, Hernandez, AM, Herranz, M, Justo, S, Lahoz, C, Nino, P, Pallares-Carratala, V, Pedro-Botet, J, Perez, AP, Royo-Bordonada, MA, Santamaria, R, Tresserras, R, Zamora, A, Zuza, I, Armario, P. Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention. Clinica E Investigacion En Arteriosclerosis. 2022; 34(4)DOI:10.1016/j.arteri.2022.03.003. PMID:35906022. IF:(Q/D).